R(−)-Denopamine
SIGMA/D7815 - ≥98% (HPLC), powder
Synonym: (−)-α-(3,4-Dimethoxyphenethylaminomethyl)-4-hydroxybenzylalcohol
CAS Number: 71771-90-9
Empirical Formula (Hill Notation): C18H23NO4
Molecular Weight: 317.38
MDL Number: MFCD00867122
Linear Formula: C18H23NO4
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C18H23NO4/c1-22-17-8-3 |
| InChI key | VHSBBVZJABQOSG-INIZCTEOSA |
| Quality Level | 100 ![]() |
| SMILES string | COc1ccc(CCNC[C@H](O)c2ccc |
| solubility | DMSO: 10 mg/mL, clear |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Application: | R(-)-Denopamine has been used as an β-adrenergic agonist to study its effects on contractility in isolated lymphatic vessels (LVs). |
| Biochem/physiol Actions: | β1-adrenoceptor agonist. |
| Biochem/physiol Actions: | Denopamine is a cardiotonic drug. |
| Disclaimer: | Light sensitive. |
| Features and Benefits: | This compound is featured on the β-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5 mg in glass bottle |
| Symbol | GHS08 |
| Signal word | Warning |
| Hazard statements | H361 |
| Precautionary statements | P281 |
| Hazard Codes | Xn |
| Risk Statements | 63-62 |
| Safety Statements | 22-36/37/39-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352116 |


